Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00443040 · ClinicalTrials.gov registry record · Phase 2
Asimadoline for the Treatment of Post-Operative Ileus
A Phase 2 study, sponsored by Tioga Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00443040 is a Phase 2 study that was terminated before completion, run by Tioga Pharmaceuticals. The registered enrollment target is 35 participants.
The verdict
NCT00443040, a Phase 2 study, was terminated before completion, sponsored by Tioga Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of asimadoline in patients who have undergone a laparoscopic segmental colectomy and determine whether it reduces the time to recovery of bowel function compared to placebo.
Interventions
- DRUG Placebo
- DRUG Asimadoline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00443040
The ClinicalTrials.gov registry entry for NCT00443040 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tioga Pharmaceuticals, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00443040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00443040 about?
NCT00443040 is a clinical study titled "Asimadoline for the Treatment of Post-Operative Ileus". The purpose of this study is to evaluate the safety and efficacy of asimadoline in patients who have undergone a laparoscopic segmental colectomy and determine whether it reduces the time to recovery of bowel function compared to placebo.
What is the current status of trial NCT00443040?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2007-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00443040?
The interventions under investigation include: Placebo (DRUG), Asimadoline (DRUG).
Who is sponsoring clinical trial NCT00443040?
This trial is sponsored by Tioga Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.